- Home
- SMBC vs RAPT Comparison
SMBC vs RAPT Comparison
Compare SMBC & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMBC
- RAPT
- Stock Information
- Founded
- SMBC 1887
- RAPT 2015
- Country
- SMBC United States
- RAPT United States
- Employees
- SMBC N/A
- RAPT N/A
- Industry
- SMBC Banks
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- SMBC Finance
- RAPT Health Care
- Exchange
- SMBC Nasdaq
- RAPT Nasdaq
- Market Cap
- SMBC 613.1M
- RAPT 498.4M
- IPO Year
- SMBC N/A
- RAPT 2019
- Fundamental
- Price
- SMBC $52.27
- RAPT $28.69
- Analyst Decision
- SMBC Hold
- RAPT Buy
- Analyst Count
- SMBC 3
- RAPT 7
- Target Price
- SMBC $64.67
- RAPT $35.14
- AVG Volume (30 Days)
- SMBC 52.5K
- RAPT 321.0K
- Earning Date
- SMBC 10-27-2025
- RAPT 11-11-2025
- Dividend Yield
- SMBC 1.73%
- RAPT N/A
- EPS Growth
- SMBC 17.20
- RAPT N/A
- EPS
- SMBC 5.18
- RAPT N/A
- Revenue
- SMBC $176,077,000.00
- RAPT N/A
- Revenue This Year
- SMBC $17.00
- RAPT N/A
- Revenue Next Year
- SMBC $7.19
- RAPT N/A
- P/E Ratio
- SMBC $10.28
- RAPT N/A
- Revenue Growth
- SMBC 9.55
- RAPT N/A
- 52 Week Low
- SMBC $45.10
- RAPT $5.67
- 52 Week High
- SMBC $68.69
- RAPT $32.35
- Technical
- Relative Strength Index (RSI)
- SMBC 38.93
- RAPT 77.62
- Support Level
- SMBC $51.43
- RAPT $24.34
- Resistance Level
- SMBC $55.19
- RAPT $32.35
- Average True Range (ATR)
- SMBC 1.11
- RAPT 2.74
- MACD
- SMBC -0.31
- RAPT 0.48
- Stochastic Oscillator
- SMBC 14.73
- RAPT 72.42
About SMBC Southern Missouri Bancorp Inc.
Southern Missouri Bancorp Inc is a USA-based holding company for Southern Missouri Savings Bank. The principal business of the bank consists of attracting retail deposits from the general public and using such deposits along with wholesale funding from the Federal Home Loan Bank of Des Moines, and to a lesser extent, brokered deposits, to invest in one- to four-family residential mortgage loans, mortgage loans secured by commercial real estate, commercial non-mortgage business loans, and consumer loans. It is engaged in providing the range of banking and financial services to individuals and corporate customers in its market areas. The company derives revenue principally from interest earned on loans, debt securities, bank card interchange fees, loan late charges and another fee income.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.